2023-08-26 00:04:48
Its diagnosis remains late because of non-specific symptoms appearing when the tumor is already advanced. The main risk factor is genetic and the essential protective factor is prolonged estrogen-progestogen oral contraception. However, thanks to therapeutic progress, the incidence of these cancers is decreasing slightly.
This file provides an update on epidemiology, new developments in care, indications for fertility preservation.
To read :
Campos A, Villermain-Lécolier C, Bazot M, et al. Imaging in ovarian cancer. Rev Prat 2022;71(6);608-17.
Sanson C. Epidemiology and risk factors of ovarian cancer. Rev Prat 2022;72(6);618-20.
Li H, Kolanska K, Prades M. Fertility preservation before treatment for ovarian cancer. Rev Prat 2022;72(6);621-6.
Azaïs H, Koual M, Bentivegna E, et al. Ovarian cancer surgery. Rev Prat 2022;72(6);627-31.
Azaïs H, Joual M, Bentivegna E, et al. Improved rehabilitation for ovarian cancer surgery. Rev Prat 2022;72(6);632.
Pautier P. Evolution of adjuvant treatments for ovarian cancer. Rev Prat 2022;72(6);633-8.
Designated C, Benusiglio PR. Oncogenetics in ovarian cancer. Rev Prat 2022;72(6);639-41.
Uzan C. Innovation in ovarian cancer: 10 key messages. Rev Prat 2022;72(6);642.
1693008620
#file #Ovarian #cancers #diagnosis #late
